Ü. YAŞAR And M. Ö. BABAOĞLU, "Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of neuroprotective EETs and sulfonylurea metabolism in relation with K-ATP channels," ACTA PHARMACOLOGICA SINICA , vol.40, no.4, pp.569-570, 2019
YAŞAR, Ü. And BABAOĞLU, M. Ö. 2019. Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of neuroprotective EETs and sulfonylurea metabolism in relation with K-ATP channels. ACTA PHARMACOLOGICA SINICA , vol.40, no.4 , 569-570.
YAŞAR, Ü., & BABAOĞLU, M. Ö., (2019). Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of neuroprotective EETs and sulfonylurea metabolism in relation with K-ATP channels. ACTA PHARMACOLOGICA SINICA , vol.40, no.4, 569-570.
YAŞAR, ÜMİT, And MELİH ÖNDER BABAOĞLU. "Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of neuroprotective EETs and sulfonylurea metabolism in relation with K-ATP channels," ACTA PHARMACOLOGICA SINICA , vol.40, no.4, 569-570, 2019
YAŞAR, ÜMİT And BABAOĞLU, MELİH Ö. . "Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of neuroprotective EETs and sulfonylurea metabolism in relation with K-ATP channels." ACTA PHARMACOLOGICA SINICA , vol.40, no.4, pp.569-570, 2019
YAŞAR, Ü. And BABAOĞLU, M. Ö. (2019) . "Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of neuroprotective EETs and sulfonylurea metabolism in relation with K-ATP channels." ACTA PHARMACOLOGICA SINICA , vol.40, no.4, pp.569-570.
@article{article, author={ÜMİT YAŞAR And author={MELİH ÖNDER BABAOĞLU}, title={Increased risk for cerebral ischemic stroke in diabetes: genetically polymorphic CYP mediated production of neuroprotective EETs and sulfonylurea metabolism in relation with K-ATP channels}, journal={ACTA PHARMACOLOGICA SINICA}, year=2019, pages={569-570} }